Stock search

Ticker or company name

Humana

HUM · NYSE · Health Care

$461,25Up +11,25 (+2,50%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$54,9 bn
Div. yield
0,7%
Year to date
+75,7%
52 weeks: $163,11$456,50

Ratio score

61/100
Ratio would watch

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

5 ✓ · 1 — · 3 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM44,021,625,1
Forward P/E26,9—16,2
PEG1,9—2,2
P/S0,40,42,2
EV/EBITDA20,012,217,3
P/FCF11,0—19,5
P/B2,92,73,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 32 analysts

Buy
19
Hold
12
Sell
1

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 2026−1,01−0,70Up +30,9%
Q2 20267,297,61Up +4,3%
Q1 202610,2910,31Up +0,2%
Q4 2025−4,05−3,96Up +2,1%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue41,2 bn40,9 bn39,6 bn32,5 bn32,6 bn32,4 bn32,1 bn29,2 bn29,4 bn29,5 bn29,6 bn26,5 bn
EPS1,335,739,83−6,591,624,5110,30−5,743,985,626,11−4,26
Margin0,4%1,7%3,0%−2,4%0,6%1,7%3,9%−2,4%1,6%2,3%2,5%−2,0%
FCF2,03 bn1,83 bn1,13 bn−1,85 bn836 m1,16 bn236 m−682 m1,73 bn1,10 bn246 m−7,42 bn

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $150 016 (1 person), sales $2,58 m.

NameAmountSharesPrice
frederick wayne a.i.10 Nov 2026 · sale$193 853440$440,58
ventura joseph c9 Nov 2026 · sale$2,38 m5 495$433,85
shetty sanjay k23 Feb 2026 · open-market purchase$150 016810$185,21

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
18 May 1971

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
IDXXIdexx Laboratories$700,6583would consider47,2+11,9%25,4%
BDXBecton Dickinson$216,4738would not consider51,8−2,6%4,5%
VEEVVeeva Systems$299,2889would consider47,3+16,5%29,3%
EWEdwards Lifesciences$107,1156would watch60,3+13,4%15,2%
BSXBoston Scientific$43,6983would consider18,4+8,9%16,6%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.